Moody National Bank Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
MCI
Moody National Bank Trust Division's REGN Position: Q2 2026 in Review
Moody National Bank Trust Division reduced its Regeneron Pharmaceuticals (REGN) stake by 0.62% in Q2 2026, selling an estimated $5.45K and leaving 1,274 shares worth $794K. The position accounts for 0.07% of the portfolio, ranked #273.
Moody National Bank Trust Division first reported a position in REGN in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.07M in Q4 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Moody National Bank Trust Division held 1,274 shares of Regeneron Pharmaceuticals worth $794K as of Q2 2026.
- Moody National Bank Trust Division sold 8 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.45K.
- Regeneron Pharmaceuticals made up 0.07% of Moody National Bank Trust Division's portfolio in Q2 2026, its #273 holding.
- Moody National Bank Trust Division first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 15 quarters since.
- Moody National Bank Trust Division's Regeneron Pharmaceuticals position peaked at $1.07M in Q4 2024.
- 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.